Who owns VERA?
Institutional ownership of Vera Therapeutics Inc. from Form 13F, Q2 2026
219 institutional managers reported holding Vera Therapeutics Inc. (VERA) in Form 13F filings for Q2 2026, with 77,932,330 shares worth $3.3B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 5,696,065 shares (+7.9%). 28 opened new positions and 37 sold out.
- Funds holding
- 219
- Value held
- $3.3B
- New / sold out
- 28 / 37
- Net shares, same filers
- +7.9%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of VERA
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $247M | 7.4% | 5,747,760 | Added |
| Avoro Capital Advisors LLC | $246M | 7.3% | 5,723,888 | Trimmed |
| State Street Corp | $178M | 5.3% | 4,148,786 | Added |
| Price T Rowe Associates Inc | $172M | 5.1% | 4,012,936 | Trimmed |
| Deep Track Capital, LP | $172M | 5.1% | 4,000,000 | Trimmed |
| Deerfield Management Company, L.p. | $168M | 5.0% | 3,916,400 | Added |
| Kynam Capital Management, LP | $124M | 3.7% | 2,890,059 | Trimmed |
| Morgan Stanley | $120M | 3.6% | 2,799,459 | Added |
| Sofinnova Investments, Inc. | $120M | 3.6% | 2,793,987 | Unchanged |
| FMR LLC | $119M | 3.6% | 2,774,070 | Added |
| Vanguard Capital Management LLC | $118M | 3.5% | 2,755,413 | Added |
| Eversept Partners, LP | $94.9M | 2.8% | 2,212,770 | Added |
| Logos Global Management LP | $94.4M | 2.8% | 2,200,000 | New |
| Integral Health Asset Management, LLC | $75.1M | 2.2% | 1,750,000 | Added |
| Bellevue Group AG | $73.4M | 2.2% | 1,710,808 | Unchanged |
| Geode Capital Management, LLC | $72.6M | 2.2% | 1,692,442 | Added |
| Alliancebernstein L.p. | $64.0M | 2.0% | 1,591,043 | Added |
| Goldman Sachs Group Inc | $59.3M | 1.8% | 1,380,835 | Added |
| Frontier Capital Management Co LLC | $55.6M | 1.7% | 1,295,405 | Added |
| Pictet Asset Management Holding SA | $53.6M | 1.6% | 1,249,414 | Added |
| Deutsche Bank Ag\ | $47.3M | 1.4% | 1,102,106 | Added |
| Qube Research & Technologies Ltd | $46.5M | 1.4% | 1,083,179 | Added |
| Woodline Partners LP | $43.0M | 1.3% | 1,001,037 | Unchanged |
| American Century Companies Inc | $37.2M | 1.1% | 866,243 | Added |
| Vanguard Portfolio Management LLC | $27.6M | 0.8% | 642,873 | Added |
Share of 13F holdings is each fund's shares as a share of the 77,932,330 VERA shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Morgan Stanley Added+$104M
- Logos Global Management LP New+$94.4M
- State Street Corp Added+$33.7M
- Frontier Capital Management Co LLC Added+$31.9M
- BlackRock, Inc. Added+$28.3M
- Deutsche Bank Ag\ Added+$24.4M
- Qube Research & Technologies Ltd Added+$23.2M
- Davern Capital Partners, LP New+$21.4M
- Great Point Partners LLC Added+$17.2M
- Voya Investment Management LLC Added+$15.1M
Biggest sellers in Q2 2026
- Vestal Point Capital, LP Sold out-$55.0M
- Point72 Asset Management, L.P. Trimmed-$50.2M
- Price T Rowe Associates Inc Trimmed-$24.1M
- Kynam Capital Management, LP Trimmed-$21.8M
- Citadel Advisors LLC Sold out-$17.3M
- First Turn Management, LLC Sold out-$17.0M
- ExodusPoint Capital Management, LP Trimmed-$13.1M
- First Light Asset Management, LLC Sold out-$12.6M
- BNP Paribas Financial Markets Trimmed-$12.3M
- Hudson Bay Capital Management LP Sold out-$7.7M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $576M and sold $323M; 98 added and 66 trimmed.
Schedule 13D and 13G filings on VERA
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-10STATE STREET CORP SCHEDULE 13G filed by Vera Therapeutics Inc.Schedule 13G
- 2026-08-07STATE STREET CORP SCHEDULE 13G filed by Vera Therapeutics Inc.Schedule 13G
- 2026-04-01Point72 Asset Management, L.P. SCHEDULE 13G filed by Vera Therapeutics Inc.Schedule 13G
- 2026-01-30VANGUARD GROUP INC SCHEDULE 13G filed by Vera Therapeutics Inc.Schedule 13G
- 2025-06-11Flynn James E SCHEDULE 13G filed by Vera Therapeutics Inc.Schedule 13G
Questions about VERA ownership
- Who owns VERA stock?
- 219 institutional investment managers reported VERA positions in their Form 13F filings for Q2 2026, holding 77,932,330 shares worth $3.3B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling VERA?
- In Q2 2026, 28 managers opened new VERA positions, 98 added, 66 trimmed and 37 sold out. Managers that filed in both quarters added a net 5,696,065 shares.
- How current is this VERA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to VERA by CUSIP. Options are left out. VERA news and filings · VERA insider trades · Top funds